301246 Hubei Hongyuan Pharmaceutical Technology
- 12.75
- +0.75+6.25%
Hubei Hongyuan Pharmaceutical Technology News
Hongyuan Pharmaceutical: An indicative announcement on the listing and circulation of some shares already issued before the initial public offering
Hongyuan Pharmaceutical: Summary table on the use of non-operating capital and other related capital transactions for the first half year of 2024
Hongyuan Pharmaceutical: Announcement on Accruing Credit Impairment Losses and Asset Impairment Losses for the Semi-Annual Period of 2024
Hubei Hongyuan Pharmaceutical Technology: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hubei Hongyuan Pharmaceutical Technology: Legal Opinion of Shanghai Tongli Law Firm on the 2023 Annual General Meeting of Shareholders of Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Hongyuan Pharmaceutical: Announcement on the 2024 Remuneration Plan for Directors, Supervisors and Senior Managers
Hongyuan Pharmaceutical: Notice on Convening the 2023 Annual General Meeting of Shareholders
Hongyuan Pharmaceutical: 2023 Internal Control Self-Assessment Report
Hongyuan Pharmaceutical: Accounting Services Selection and Employment System (established in April 2024)
Hongyuan Pharmaceutical: External Guarantee System (revised in April 2024)
Hongyuan Pharmaceutical: Summary table on the use of non-operating capital and other related capital transactions by listed companies in 2023
Hongyuan Pharmaceutical: Rules of Work for the Audit Committee of the Board of Directors (revised in April 2024)
Hongyuan Pharmaceutical: Articles of Association (revised in April 2024)
Hongyuan Pharmaceutical: Announcement on Accruing Credit Impairment Losses and Asset Impairment Losses in 2023
Hongyuan Pharmaceutical: Special Meeting Work System for Independent Directors (established in April 2024)
Hongyuan Pharmaceutical: Rules of Procedure for the Board of Directors (Revised in April 2024)
Hongyuan Pharmaceutical: Rules of Work for the Strategy Committee of the Board of Directors (enacted in April 2024)
Hongyuan Pharmaceutical: Working Rules of the Board of Directors Remuneration and Assessment Committee (revised in April 2024)
Hongyuan Pharmaceutical: Annual Report Work System for Independent Directors (Revised in April 2024)
Hongyuan Pharmaceutical: Announcement on amending the “Articles of Association”
Analysis
Price Target
No Data
No Data